Highbridge Capital Management LLC Global Blood Therapeutics, Inc. Transaction History

Highbridge Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $3.63 Million - $4.63 Million	-80,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $2.1 Million - $2.53 Million	40,000 Added 100.0%	80,000 $4.21 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $399,900 - $534,800	-10,000 Reduced 20.0%	40,000 $2.12 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $650,827 - $963,035	-20,635 Reduced 29.21%	50,000 $2.05 Million
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $2.68 Million - $3.61 Million	70,635 New	70,635 $2.68 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.